BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37584772)

  • 21. Salvage hepatectomy for local recurrence of hepatocellular carcinomas offers survival comparable to that of matched patients who undergo primary hepatectomies.
    Kishi Y; Nara S; Esaki M; Hiraoka N; Shimada K
    Eur J Surg Oncol; 2017 Jun; 43(6):1076-1082. PubMed ID: 28456443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
    Shimozawa N; Hanazaki K
    J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact on Oncological Outcomes and Intent-to-Treat Survival of Resection Margin for Transplantable Hepatocellular Carcinoma in All-Comers and in Patients with Cirrhosis: A Multicenter Study.
    Lim C; Goumard C; Casellas-Robert M; Lopez-Ben S; Lladó L; Busquets J; Salloum C; Albiol-Quer MT; Castro-Gutiérrez E; Rosmorduc O; Feray C; Ramos E; Figueras J; Scatton O; Azoulay D
    World J Surg; 2020 Jun; 44(6):1966-1974. PubMed ID: 32095855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria.
    Imura S; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Saito Y; Iwahashi S; Ikemoto T; Morine Y; Shimada M
    Int J Clin Oncol; 2018 Feb; 23(1):98-103. PubMed ID: 28875240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience.
    Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    Anticancer Res; 2013 Nov; 33(11):5097-105. PubMed ID: 24222155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.
    Huang ZY; Liang BY; Xiong M; Zhan DQ; Wei S; Wang GP; Chen YF; Chen XP
    Ann Surg Oncol; 2012 Aug; 19(8):2515-25. PubMed ID: 22395985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor size may influence the prognosis of solitary hepatocellular carcinoma patients with cirrhosis and without macrovascular invasion after hepatectomy.
    Liang BY; Gu J; Xiong M; Zhang EL; Zhang ZY; Chen XP; Huang ZY
    Sci Rep; 2021 Aug; 11(1):16343. PubMed ID: 34381132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
    Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
    J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeat hepatectomy for patients with early and late recurrence of hepatocellular carcinoma: A multicenter propensity score matching analysis.
    Xing H; Sun LY; Yan WT; Quan B; Liang L; Li C; Zhou YH; Wang H; Zhong JH; Gu WM; Chen TH; Wang MD; Wu H; Pawlik TM; Lau WY; Wu MC; Shen F; Yang T
    Surgery; 2021 Apr; 169(4):911-920. PubMed ID: 31879090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer.
    Matsuda M; Fujii H; Kono H; Matsumoto Y
    J Hepatobiliary Pancreat Surg; 2001; 8(4):353-9. PubMed ID: 11521181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study.
    Liang HH; Chen MS; Peng ZW; Zhang YJ; Zhang YQ; Li JQ; Lau WY
    Ann Surg Oncol; 2008 Dec; 15(12):3484-93. PubMed ID: 18679754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MTM-HCC at Previous Liver Resection as a Predictor of Overall Survival in Salvage Liver Transplantation.
    Yang Y; Sun JH; Tan XY; Lu CD; Huang ZP; Zhu HD; Shi XT; Chen JX; Fang JZ
    Dig Dis Sci; 2023 Jun; 68(6):2768-2777. PubMed ID: 36790686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients.
    Zhang TT; Zhao XQ; Liu Z; Mao ZY; Bai L
    Clin Transl Oncol; 2016 Aug; 18(8):831-40. PubMed ID: 26577107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection.
    Pelizzaro F; Trevisani F; Simeon V; Vitale A; Cillo U; Piscaglia F; Missale G; Sangiovanni A; Foschi FG; Cabibbo G; Caturelli E; Di Marco M; Azzaroli F; Brunetto MR; Raimondo G; Vidili G; Guarino M; Gasbarrini A; Campani C; Svegliati-Baroni G; Giannini EG; Mega A; Masotto A; Rapaccini GL; Magalotti D; Sacco R; Nardone G; Farinati F;
    Liver Int; 2023 Dec; 43(12):2762-2775. PubMed ID: 37753540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeat hepatectomy for recurrent hepatocellular carcinoma.
    Itamoto T; Nakahara H; Amano H; Kohashi T; Ohdan H; Tashiro H; Asahara T
    Surgery; 2007 May; 141(5):589-97. PubMed ID: 17462458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeat hepatectomy versus microwave ablation for solitary and small (≤3 cm) recurrent hepatocellular carcinoma with early or late recurrence: A propensity score matched study.
    Wang WQ; Lv X; Li J; Li J; Wang JL; Yuan T; Liu JJ; Zhu RH; Huang ZY; Zhang EL
    Eur J Surg Oncol; 2023 May; 49(5):1001-1008. PubMed ID: 36585301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.